Related Experiment Video
Updated: May 29, 2026
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and
Aleksandra Banaszkiewicz1, Kinga Kowalska-Duplaga, Tomasz Pytrus
1Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, Poland. aleksandra.banaszkiewicz@gmail.com
Insights
Clostridium difficile infection (CDI) is common in newly diagnosed pediatric inflammatory bowel disease (IBD) patients. The high prevalence of CDI was linked to patient age and disease severity, regardless of IBD type.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Inflammatory Bowel Disease Research
Background:
- Emerging data link Clostridium difficile infection (CDI) to the onset of inflammatory bowel disease (IBD).
- Understanding CDI prevalence in pediatric IBD is crucial for early diagnosis and management.
Purpose of the Study:
- To determine the prevalence of CDI in newly diagnosed pediatric IBD patients.
- To identify risk factors associated with CDI in this population.
Main Methods:
- Retrospective study of pediatric IBD patients diagnosed between 2007-2010.
- Diagnosis confirmed by Porto criteria; CDI screening via stool enzyme immunoassay.
- Evaluated risk factors: prior hospitalization, recent antibiotic use, colonic involvement, symptom duration.
Main Results:
- 134 pediatric IBD patients evaluated (54 Crohn's disease, 80 ulcerative colitis); 87% had colonic disease.
- CDI prevalence was 47% (95% CI, 38%-56%), with no significant difference between Crohn's disease and ulcerative colitis.
- Increased CDI risk correlated with higher patient age and greater disease severity.
Conclusions:
- A high prevalence of CDI was observed in newly diagnosed pediatric IBD patients.
- CDI occurrence was independent of the specific type of IBD (Crohn's disease vs. ulcerative colitis).
- Age and disease severity are key factors influencing CDI risk in pediatric IBD.
Background:
Epidemiological and microbiological data suggest that Clostridium difficile infection (CDI) plays a substantial role in the clinical initiation of inflammatory bowel disease (IBD). The aim of the present study was to investigate the prevalence and risk factors of CDI in newly diagnosed pediatric patients with IBD.
Methods:
The current investigation was a retrospective study. All patients newly diagnosed with IBD in the pediatric gastroenterology clinic in Warsaw between 2007 and 2010 were included in the present study. The patients were diagnosed according to Porto criteria and microbiology evaluation screening tests for CDI were conducted. Risk factors including prior hospitalization, use of antibiotics within 2 months of CDI detection, colonic involvement, and the duration of symptoms were evaluated. CDI diagnosis was based on a positive stool enzyme immunoassay.
Results:
In the present study, 134 patients were evaluated (54 patients with Crohn's disease, and 80 with ulcerative colitis; 87% of the patients had colonic disease). The average age of the patients was 12.3 years, and the prevalence of CDI was 47% (95% confidence interval [CI], 38%-56%). Significant differences in the prevalence of CDI between patients with Crohn's disease and ulcerative colitis (P = 0.72; odds ratio [OR] = 1.187, 95% CI, 0.56-2.52) were not observed. The risk of CDI was associated with an increase in the age of the patient and the severity of the disease.
Conclusions:
The prevalence of CDI in newly diagnosed IBD patients was high and was independent of the type of disease.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:26Inflammatory Bowel Disease I: Introduction
01:20Inflammatory Bowel Disease IV: Clinical Manifestations